Bumrungrad Hospital Public Company Limited (BUGDF) Comparison with companies in other sectors?

Bumrungrad Hospital Public Company Limited has a share price of 794.96M. You can analyze Bumrungrad Hospital Public Company Limited (BUGDF) competitors across different market sectors through stock heatmaps.

What are BUGDF's NET and operating margins?

Bumrungrad Hospital Public Company Limited (BUGDF) operating margin is around 0.35, and net profit margin is approximately 0.30 as of the latest reports.

In what way does BUGDF's earnings per share (EPS) trend reflect its financial momentum?

Bumrungrad Hospital Public Company Limited (BUGDF) EPS is 0.27 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Bumrungrad Hospital Public Company Limited is 15.67, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Bumrungrad Hospital Public Company Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Bumrungrad Hospital Public Company Limited like P/E which is 14.45, P/B which is 3.72, and PEG which is -0.14. Compare them with sector averages to evaluate if the stock is priced fairly.

Bumrungrad Hospital Public Company Limited

BUGDF•PNK

Healthcare

Medical - Care Facilities

$4.23

$0.00(0.00%)

Fundamental Analysis of Bumrungrad Hospital Public Company Limited (BUGDF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.27

P/E Ratio

15.67

ROE

0.28%

Net Margin

0.30%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.36B

Shares OutstandingTotal number of shares issued

$794.96M

Book Value/ShareNet worth per share

$37.16

Revenue/ShareAnnual revenue per share

$31.83

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.27

Net MarginNet income as percentage of revenue

29.74%

Operating MarginOperating income as percentage of revenue

34.76%

ROEReturn on shareholders' equity

28.08%

ROAReturn on total assets

21.92%

ROCEReturn on capital employed

28.76%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$8.91

Cash/ShareCash and equivalents per share

$17.60

FCF YieldFree cash flow as percentage of market cap

6.51%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$4.76

Dividend YieldAnnual dividend as percentage of stock price

3.48%

Financial Ratios Analysis data is not available for BUGDFFinancial Ratios Analysis details for BUGDF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BUGDFSector Benchmarking details for BUGDF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Bumrungrad Hospital Public Company Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Bumrungrad Hospital Public Company Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Bumrungrad Hospital Public Company Limited's unique business strengths and challenges.

Key Financial Metrics for Bumrungrad Hospital Public Company Limited

For Bumrungrad Hospital Public Company Limited, essential financial indicators include EPS 0.27, PE 15.67, and ROE 0.28. These key ratios reveal insights into Bumrungrad Hospital Public Company Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Bumrungrad Hospital Public Company Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Bumrungrad Hospital Public Company Limited

Metrics like Net Margin 29.74% and ROA 21.92% shed light on how well Bumrungrad Hospital Public Company Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Bumrungrad Hospital Public Company Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Bumrungrad Hospital Public Company Limited

Using ratios such as P/B Ratio 3.72 and PEG Ratio -0.14, investors can assess whether Bumrungrad Hospital Public Company Limited is appropriately valued based on its financials and growth potential. These figures, combined with Bumrungrad Hospital Public Company Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Bumrungrad Hospital Public Company Limited

Financial health indicators, such as Debt/Equity Ratio 0.005 and Cash Flow $8.91, provide a snapshot of Bumrungrad Hospital Public Company Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Bumrungrad Hospital Public Company Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Bumrungrad Hospital Public Company Limited

Investing in Bumrungrad Hospital Public Company Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Bumrungrad Hospital Public Company Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;